|
Real-time Estimate
Cboe BZX
21:53:59 18/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 26.54 USD | +2.45% |
|
-7.09% | -14.19% |
| 08-14 | Oppenheimer Adjusts Pelthos Therapeutics PT to $64 From $66, Maintains Outperform Rating | MT |
| 08-13 | Pelthos Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.45% | -7.09% | -2.42% | +1.72% | -14.19% | +25.12% | - | - | - | 90.02M | |
| +3.26% | +0.39% | +6.36% | +23.45% | +13.50% | +74.74% | +123.23% | +354.26% | +1,428.94% | 1,055B | |
| +3.15% | +4.13% | +8.72% | +18.17% | +30.72% | +53.49% | +56.84% | +52.68% | +124.09% | 632B | |
| +2.93% | +2.91% | +1.57% | +22.90% | +12.64% | +24.59% | +71.41% | +119.42% | +285.44% | 442B | |
| +1.35% | -2.17% | +8.80% | +12.19% | +9.96% | +40.98% | +41.50% | -3.13% | +48.27% | 351B | |
| +1.75% | -0.24% | +2.00% | +7.13% | +14.56% | +25.28% | +40.46% | +44.74% | +60.05% | 290B | |
| +2.13% | -0.32% | -4.64% | -13.89% | -14.39% | +0.58% | +10.77% | +35.20% | +133.97% | 243B | |
| +1.65% | +2.86% | +17.02% | +31.37% | +30.20% | +45.63% | +62.76% | +87.86% | +143.86% | 227B | |
| +1.35% | -3.53% | -9.65% | +3.62% | -8.89% | -14.72% | -52.63% | -11.46% | +91.50% | 200B | |
| +3.11% | +5.52% | +7.55% | +10.49% | +16.73% | +21.43% | +88.81% | +99.10% | +77.78% | 172B | |
| +1.40% | +2.36% | +10.10% | +7.58% | +9.43% | +8.69% | -25.67% | -44.74% | -22.57% | 153B | |
| +2.54% | +4.23% | +10.21% | +15.69% | +22.91% | +37.58% | +6.83% | -2.40% | +12.99% | 132B | |
| +2.49% | -0.24% | +9.96% | +21.02% | +16.54% | +35.52% | +53.23% | +171.27% | +433.15% | 131B | |
| +1.32% | +3.01% | +0.99% | +4.48% | -6.10% | -9.24% | -20.74% | -13.36% | +10.69% | 106B | |
| +1.97% | -0.42% | +0.32% | +0.61% | +3.48% | +31.20% | +39.96% | -1.01% | -9.80% | 101B | |
| -0.25% | -3.73% | -6.53% | -13.74% | -16.94% | +9.67% | +60.31% | +68.27% | +491.11% | 70.87B | |
| +3.43% | +2.15% | +4.05% | +8.05% | +17.93% | +29.33% | +28.45% | +56.18% | +21.58% | 55.24B | |
| +1.75% | -0.43% | +3.02% | +28.84% | +31.69% | +76.15% | -3.14% | +1.72% | -49.65% | 54.51B | |
| -0.95% | -3.34% | -1.54% | -3.00% | -12.09% | -17.40% | +29.09% | -4.35% | +214.56% | 51.66B | |
| +1.36% | +1.44% | +19.37% | +8.74% | +18.57% | +104.90% | +287.08% | +292.00% | -30.25% | 42.49B | |
| Average | +1.94% | -1.91% | +4.26% | +9.77% | +8.81% | +30.18% | +47.29% | +68.54% | +182.41% | 225.51B | |
| Weighted average by Cap. | +2.44% | -1.74% | +5.25% | +14.80% | +13.18% | +39.81% | +59.97% | +121.67% | +430.39% |
- Stock Market
- Stocks
- PTHS Stock
- Sector Pelthos Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
